Blake Byers
blakebyers.com · 561 words · saved by 2 readers
Building and investing in Longevity, Foundation Models, AI Drug Development, AI Robots, Codegen, and Brain Computer Interfaces.
I work on projects that can positively bend the arc of humanity over multiple generations, or are just fun, ideally both. Please reach out, my email is not that hard to find. Twitter @byersblake. Investing I am an avowed generalist. I’ve backed early stage companies across personal finance, cancer treatments, quantum computing, blood screening, and enterprise software that have all gone public. My current investments include superintelligence, mathematical reasoning, coding agents, AI drug development, brain computer interfaces and human longevity. Neuralink - Series B. Brain computer…
saved by
related reading
- Coatue's Philippe Laffont on SpaceX IPO, the AI Bubble, & Anthropic at $5 Trillionyoutube.com
- CNBC Squawk Box with Brad Gerstner - October 21st, 2026youtube.com
- Thomas Laffont: The $4T AI IPO Wave Is Coming… and We’ve Never Seen Anything Like Ityoutube.com
- Philippe Laffont on the Intelligence Age, AI Infrastructure & the Model Race | CNBC Squawk Boxyoutube.com
- Sam Altman, Co-Founder and CEO of OpenAI: Staying Human While Scaling Superintelligenceyoutube.com
- near.blognear.blog
- Elad Gileladgil.com
- Jay Azhangjayazhang.com
- Amaranth Foundation - Longevity and Neuroscienceamaranth.foundation
- Brain-Computer Interfaces: Exploring the Last Frontier — byFoundersbyfounders.vc
- AI Grantaigrant.com
- List of Biotechnology Companies to Watch – AI Expanded Versionsubstack.com